Genomic Biomarkers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
Supplementary figures and tables
应用场景：
创建时间：
2022-06-01
相关数据集
DataSheet_1_Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors.pdf
Despite the success of antiestrogens in extending overall survival of patients with estrogen receptor positive (ER+) breast tumors, resistance to these therapies is prevalent. ER+ tumors that progress
NIAID Data Ecosystem60
Acquisition of CCDC88A/GIV through Tumor-Stroma Tunnels Promotes Aggressive Phenotypes of Estrogen Receptor-Positive Breast Cancer.. Acquisition of CCDC88A/GIV through Tumor-Stroma Tunnels Promotes Aggressive Phenotypes of Estrogen Receptor-Positive Breast Cancer.
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
NIAID Data Ecosystem40
Tamoxifen-resistant human breast cancer cell lines
Tamoxifen-resistant human breast cancer cell lines
ChEBI2009-12-09 更新00
circRNA sequencing in breast cancer patient tissues
we identified a circular RNA circARHGAP12, which was high-expressed in trastuzumab resistant HER2+ BC tumors and cell lines. We proved that circARHGAP12 promoted trastuzumab resistance by interacting
NIAID Data Ecosystem40
Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance [ChIP-Seq]. Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance [ChIP-Seq]
Cellular plasticity has emerged as an important mechanism of therapy resistance in cancers, yet the underlying molecular mechanisms remain unclear. Using an established breast cancer cellular model fo
NIAID Data Ecosystem20
